Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions

@inproceedings{Vajro2012TherapeuticOI,
  title={Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions},
  author={Pietro Vajro and Selvaggia Lenta and Claudio Pignata and Mariacarolina Salerno and Roberta D’Aniello and Ida De Micco and Giulia Paolella and Giancarlo Parenti},
  booktitle={Italian Journal of Pediatrics},
  year={2012}
}
The epidemics of overweight and obesity has resulted in a significant increase of non alcoholic fatty liver disease (NAFLD), a potentially progressive condition. Currently, obesity related hepatopathy represents therefore the main cause of pediatric chronic liver disease. The first choice treatment at all ages is weight loss and/or lifestyle changes, however compliance is very poor and a pharmacological approach has become necessary. In the present article we present a systematic literature… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target

M Fuchs
  • J Lipids
  • 2012
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Childhood obesity for pediatric gastroenterologists.

  • Journal of pediatric gastroenterology and nutrition
  • 2013
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

R Aller, DA De Luis, +5 authors J Gonzalez
  • Eur Rev Med Pharmacol Sci
  • 2011
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL